Engflag

Natalac

Quick links to important sections

Natalac

Natalac_FR

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Natalac

Property Description
Active ingredient Moringa oleifera (Malunggay) Leaf Powder
Form Capsule (Oral)
Pharmacological class Galactogogue, Lactation Enhancer
Common use Supporting breast milk production and flow
Origin Natural, Botanical

What Type of Supplement is Natalac?

Natalac is classified as a commercially available health food supplement or dietary adjunct, specifically positioned as a lactation enhancer for nursing mothers. This preparation is administered via the oral route in a standardized capsule form. It is consistently categorized by its high-level pharmacological function as a galactogogue, an agent intended to promote the initiation and support the maintenance of milk production. The product is used exclusively by lactating mothers who are seeking nutritional support to optimize their milk supply. The support of breastfeeding is globally recognized as essential for maternal and child health.

Composition and Origin: The Malunggay Component

The differentiating feature of Natalac lies in its core active ingredient: the powdered leaf of Malunggay (Moringa oleifera), emphasizing its natural, botanical origin. This ingredient provides a dense concentration of vitamins, minerals, and amino acids, qualifying it as a nutrient-rich food source supplement, with its efficacy clinically recognized for promoting milk secretion. Scientific literature supports the traditional use of Moringa oleifera as an effective galactagogue. The product is available as a single active ingredient item or as a combination product in variants (e.g., Natalac-FeFol), which are often fortified with critical post-natal nutrients, including Elemental Iron, Folic Acid, and Vitamin B12, providing a supplemental regimen intended to help address common nutritional deficiencies in mothers.

General Purpose: Supporting Milk Production

The primary purpose of Natalac is to provide supportive care for lactating mothers aiming to sustain or increase their overall milk supply. As a product containing the traditional galactogogue Moringa oleifera, its general action is to support the biological pathways involved in the secretion and flow of milk. A typical use scenario involves mothers requiring assistance in establishing a consistent and adequate milk output in the early post-partum period. The formulation offers comprehensive nutritional support that helps bolster maternal health, which is essential for maintaining consistent milk output for the infant.

Regulatory References

  1. WHO Recommendations on Breastfeeding

What side effects are possible with Natalac?

Possible Side Effects and Safety Information

As a supplement containing Moringa oleifera leaf powder, Natalac does not have a standardized, government-issued Prescribing Information (such as an EMA SmPC or FDA DailyMed Label) that formally classifies adverse effects by frequency.

Adverse Reaction Scope

Category Description
Key adverse reaction categories Severe Systemic Infection (linked to product quality issues) and potential Severe Cutaneous Reactions (documented in non-categorized scientific literature).
Frequency classification Frequency Not Known. No established frequency categories (e.g., common, rare) are defined by regulatory authorities.
System-organ classes involved Gastrointestinal System (associated with severe infection from contamination) and Dermatological System (linked to reports of severe skin reactions like Stevens-Johnson Syndrome).
Serious adverse reactions Severe Systemic Infection (Salmonellosis): Documented serious adverse event caused by microbial contamination in specific products, as investigated by the U.S. FDA and CDC.
Population-specific safety considerations Increased Vulnerability: Official regulatory reports note that children younger than five, older adults, and people with weakened immune systems are more likely to experience severe systemic illness if exposed to contaminated product.
Dose- or exposure-related patterns None explicitly documented in official regulatory documents for the leaf powder regarding risk increase over time or duration of use.
Safety-related restrictions or limitations The primary safety focus is the Administration-Agnostic Constraint of product quality, specifically the risk of microbial contamination (e.g., Salmonella), which can lead to severe adverse health outcomes.

Safety Classifications (High-Level)

Category Description
Regulatory frequency framework used Not applicable; classified as Frequency Not Known due to the lack of a prescription drug monograph.
Regulatory basis Primarily based on FDA Public Health Warnings, Outbreak Investigations, and NIH/LactMed reviews of safety data.
Context-of-use safety notes Data regarding the safety and effects on breastfed infants and maternal-infant levels is not reliably established in major government databases.

Connection to the overall safety profile: The official safety information for this botanical ingredient emphasizes that the risk profile is dictated less by intrinsic pharmacological side effects and more by extrinsic safety constraints related to product quality, such as contamination risk. The regulatory safety structure highlights the necessity for stringent product quality control over the classification of intrinsic adverse reactions.

Overdose and Emergency Response

Overdose and when to seek help

The following information is strictly based on official government regulatory documents and safety assessments concerning the product's botanical component.

Overdose scope

Feature Official Regulatory Statement
Documented overdose presentations No specific symptom profile is formally documented in regulatory prescribing information for Moringa oleifera leaf powder.
Physiological systems affected (as stated in label) Government safety reviews note a potential for adverse effects on the hepatic system (liver).
Dose-related or exposure-related factors (if applicable) Risk is linked to ingestion exceeding recommended amounts. Separately, food safety agencies document the risk of contamination leading to bacterial infection (e.g., Salmonella) during outbreaks.
Population-specific overdose notes (if applicable) No specific population-based considerations are documented in the available official regulatory data.
Emergency-response statements (as written in official documents) Seek immediate medical attention or consult with a licensed health-care provider for treatment advice if signs of severe adverse effects or toxicity develop.
When immediate medical help is required (label-derived phrasing only) Urgent medical consultation is required if clinical manifestations related to liver injury (such as jaundice, persistent nausea, or dark urine) are suspected, or if symptoms of acute foodborne illness are present.

Overdose classifications (high-level)

Classification Aspect Official Regulatory Statement
Severity classification (as defined in official documents) The most severe outcome cited in government-affiliated reviews is classified as clinically apparent liver injury (hepatotoxicity).
Regulatory basis (EMA / FDA / etc.) Information derived from government-hosted drug and toxicity databases (e.g., NIH LiverTox) concerning the botanical component.
Overdose-context constraints (as defined in official documents) No specific antidote is known for the botanical component; management is limited to symptomatic and supportive treatment.

Resulting overdose structure

Official overdose statements:

  • The regulatory profile establishes no specific overdose symptom profile for the product's active ingredient.
  • Government safety reviews cite the potential for rare hepatotoxicity (liver injury) linked to the botanical active ingredient.
  • Over-ingestion management requires symptomatic and supportive treatment, as no specific antidote is known.
  • Immediate medical attention is required upon the manifestation of any signs of severe toxicity, particularly those affecting the liver, or signs of acute foodborne illness.

Connection to the overall overdose profile: The overdose profile is structured around the absence of defined pharmaceutical toxicity and the imperative to monitor for the most serious event acknowledged by government reviews: hepatotoxicity. This lack of specific data mandates that users seek immediate medical attention for required symptomatic and supportive management, as there is no specific antidote or formalized intervention listed for this product.

Therapeutic Uses of Natalac

What Natalac Treats: Main Uses and Benefits

The botanical component in this supplement has been traditionally used as a galactagogue to support lactation. Natalac is commonly used to help with challenges related to lactation insufficiency, a condition that may interfere with daily functioning in the postpartum period. This supplement supports the body's processes relevant to the quantity of milk produced, which is relevant for managing symptoms that create noticeable physiological strain.

The primary therapeutic focus is on addressing symptomatic domains such as low milk supply, suboptimal milk output, and functional difficulties related to milk flow. By assisting in maximizing output, it contributes to improved comfort during phases when symptomatic assistance is needed to establish a steady milk supply. It also supports general well-being during symptomatic phases by contributing to the management of the mother’s nutritional needs.

“The primary goal of this supportive therapy is to ease the burden of inconsistent supply and help mothers cope more steadily with the demands of sustained lactation.”

The supplement is applied in clinical settings that involve temporary physiological imbalance and is relevant for managing symptoms that may appear suddenly or fluctuate during the demanding postpartum period.

Quick Fact: Relief for Low Milk Supply

Natalac supports the physiological processes related to lactation, contributing to the enhancement of breast milk volume and the stability of milk flow, which supports the efforts to achieve sustained long-term output.

Regulatory References

  1. Moringa - Drugs and Lactation Database (LactMed®)

Eligibility and Restrictions for Use

Eligibility Scope

Natalac is officially regulated for use only by the established patient population: Adult, Lactating Mothers (nursing women) seeking to support milk production.

Eligibility Status Affected Population or Condition Regulatory Statement
Contraindicated Individuals with known hypersensitivity or allergy to Moringa oleifera leaf powder or any capsule component. Absolute non-eligibility based on documented patient-specific reaction to the ingredients.
Conditional Use Individuals at higher risk for blood clots or those with bleeding disorders. Caution is advised, as the ingredient has a documented potential to affect blood clotting.
Conditional Use Patients with diabetes or conditions prone to hypoglycemia (low blood sugar). Caution is advised due to the ingredient’s documented potential to lower blood glucose levels.
Specific Restriction Pregnant Women (non-lactating). Official warnings advise against the use of the root, bark, or flowers of the plant during pregnancy, classifying these parts as possibly unsafe.
Not Established Adolescent or Geriatric populations. Use is not formally established for lactation enhancement outside the adult postpartum demographic.

Connection to the Overall Eligibility Profile

Government regulatory documents define eligibility for Natalac strictly by the product's primary function, permitting consumption by Adult Lactating Mothers. Non-eligibility is explicitly dictated by a known allergy to the active ingredient or by regulatory warnings that classify the product as conditional or restricted for patients with underlying conditions such as blood clotting risks and hypoglycemia. This structure ensures use remains within the established demographic and safety constraints.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Natalac, containing Moringa oleifera leaf powder, is derived from regulatory findings for the active botanical component, as no formal drug Prescribing Information exists. The official documentation identifies potential Additive Pharmacodynamic Effects and specific Exposure-Altering Outcomes with other medicinal products.

Pharmacodynamic and Exposure Effects

The ingredient may be associated with additive blood pressure-lowering effects when co-administered with antihypertensive drugs, and additive blood sugar-lowering effects when taken with antidiabetic medicines. Regulatory reviews also note that the component may possess a pro-clotting activity, which is relevant to consideration when used alongside anticoagulants or antiplatelet agents. An Exposure-Altering Outcome is documented concerning the potential to decrease the absorption of Levothyroxine, which may reduce the thyroid medicine's effectiveness.

Pharmacokinetic and Regulatory Constraints

A formal pharmacokinetic evaluation found that co-administration of the leaf powder did not significantly alter the steady-state exposure of the antiretroviral agent, Nevirapine. No mandatory dose timing separation rules or formal contraindications are specified in regulatory documents. However, official sources have documented a Product-Substance Risk involving investigations into microbial contamination (e.g., Salmonella) associated with the leaf powder supply chain. The overall profile emphasizes documented potential effects rather than formal drug-interaction classifications.

Mechanism of Action

How Natalac Works

1. Neuroendocrine Pathway Modulation

Natalac's mechanism of action primarily involves modulating activity within the neuroendocrine pathway responsible for prolactin release. By influencing specific central receptors, the ingredient alters signals that normally inhibit the release of this hormone from the pituitary gland.

2. Signal Transduction for Secretory Cell Activation

The resulting increase in circulating prolactin levels initiates a key signal transduction cascade within the mammary secretory cells. This cascade modifies early molecular steps, leading to the activation of cellular machinery and the expression of genes required for the synthesis of milk components.

3. Modulation of the Physiological Secretory Response

This targeted action modulates the activity of the physiological secretory response. By engaging mechanisms that influence neuro-humoral mediator levels, Natalac results in an altered secretory state, leading to physiological adjustments that reflect the mechanistic activity.

Dosage and Administration Information

Natalac is a preparation of Moringa oleifera (Malunggay) leaf powder that is categorized as a Food Supplement with No Approved Therapeutic Claims. The instructions for its use are administrative, focusing on the safe and straightforward daily intake of the capsule to provide nutritional support.

Administration Guidelines

Administration is constrained to the oral route, defining it as a capsule meant to be swallowed. The standard labeled dosage is based on the specific strength of the Malunggay component. The standard adult regimen is 1 to 2 capsules daily for the 250 mg strength. For variants fortified with essential nutrients, such as iron and folic acid, the labeled instruction is typically 1 capsule daily.

Official Use Condition Labeled Instruction
Dosing Frequency Once to twice daily.
Timing with Meals May be taken with or without food.
Target Population Explicitly for nursing/lactating mothers.

This simple regimen establishes a consistent pattern of use that is independent of mealtimes, offering flexibility for the user. The capsule requires no specialized preparation, such as dilution or reconstitution. The official use protocol dictates that the supplement is used as a continuous nutritional support regimen, intended to be taken indefinitely throughout the duration of the breastfeeding period to maintain daily nutritional intake.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Natalac

The research for Natalac's core active ingredient, Malunggay (Moringa oleifera) leaf powder, has explored its traditional use as an agent to support lactation. This evidence base includes systematic reviews, meta-analyses, and small-scale Randomized Controlled Trials (RCTs). These studies contribute to the broader evidence landscape by showing what has been observed so far regarding patterns observed in lactation and nutritional status.

Evidence for Use in Supporting Lactation Insufficiency

Research has explored the supplement's use in mothers experiencing lactation insufficiency. Studies conducted during periods of increased symptom activity include short-term randomized controlled trials (RCTs), where the supplement was compared against a placebo or control, and subsequent systematic reviews that consolidate data from multiple trials. These studies examined whether the supplement was associated with changes in measured milk output.

The primary outcomes measured in these studies included total breast milk volume (in milliliters) and changes in the hormonal biomarker serum prolactin levels. Studies report how symptoms evolved in the observed populations, with some trials describing patterns such as higher measurements of daily milk volume in the supplement group compared to control groups. However, findings were mixed, and some studies did not report a statistically significant difference compared to the control group regarding milk volume or infant weight gain.

Evidence for Use in Maternal Nutritional Support

Research has also examined the nutritional components of Moringa oleifera and how these were studied in relation to maternal nutritional status. These studies include longitudinal studies that were observed over defined time intervals and intervention studies that examined nutrient status biomarkers. The research examined changes in the nutritional composition of human milk, specifically analyzing levels of certain micronutrients like Vitamin A and Carotenoids.

Studies monitored outcomes related to measured concentrations of certain micronutrients, such as Vitamin A, in the breast milk of mothers receiving the supplement. Studies reported measurements of maternal nutritional biomarkers in some of the study cohorts. However, the data concerning the supplement's ability to significantly alter the levels of other key nutrients in breast milk have been reported as mixed or inconclusive.

Understanding the Quality and Limitations of the Evidence

The existing evidence for Moringa oleifera for lactation is broadly described as having Moderate certainty, reflecting the presence of systematic reviews and randomized trials. However, evidence quality varies across studies due to several limitations. Many of the supporting trials have sample sizes that were modest, and follow-up durations were limited, preventing a clear understanding of sustained observations over time. This heterogeneity in research contributes to the mixed findings reported in the literature.

Frequently Asked Questions (FAQ)

Common questions about Natalac (FAQ)

Q: Is Natalac available without a prescription?

Yes. Since Natalac is officially classified and regulated as a food or dietary supplement and not an approved drug, it is typically sold as an over-the-counter (OTC) product.

Q: What does 'therapeutic effect' mean for Natalac?

The product is officially classified and regulated as a food supplement. This regulatory classification means it does not have an official, government-approved therapeutic claim for treating, diagnosing, mitigating, or preventing any specific disease or medical condition.

Q: How quickly should I expect Natalac to start working?

Research evidence on the supplement's action is limited and mixed. Some research tracking the product's effect on breast milk volume suggests that changes in output might begin to be observed within a day after starting the supplement.

Q: Can Natalac cause unusual sleepiness or fatigue?

Official documents report the active ingredient is generally well tolerated. While this effect is not common, one specific case report mentioned experiencing fatigue upon restarting the product.

Q: Is it normal for Natalac to make me feel slightly dizzy?

The active ingredient is generally described in official summaries as being well tolerated. There is no specific regulatory warning or widely reported adverse event linking the supplement's active ingredient to dizziness in clinical data.

Q: Are there any common digestive side effects with Natalac?

Studies on nursing mothers found the supplement to be well tolerated with no adverse effects. Regulatory summaries indicate that the Moringa leaf ingredient is reported to have a potential laxative effect, which may cause temporary changes in bowel movements.

Q: Does Natalac interact with birth control pills?

The interaction between the active ingredient and hormonal contraceptives is not well documented in regulatory summaries. Official sources classify the evidence regarding the ingredient's potential effect on birth control as insufficient and unreliable from human trials.

Q: Is Natalac safe for people with known kidney conditions?

The safety of the supplement has not been reliably established by human clinical trials for people with known kidney disease, and official documents do not provide specific guidance for this population.

Q: Can individuals with a history of liver issues use Natalac?

The ingredient is typically reported as well tolerated, with no changes to liver tests noted in most clinical trials. However, one case report linked the use of the product to a recurrence of non-jaundiced serum enzyme elevations upon restarting in a sensitive individual.

Q: Is Natalac considered a controlled substance?

No. Regulatory resources classify the active component as an herb or alternative therapy and a food supplement. It is not listed or classified by any major authority as a controlled substance.

Q: What is the risk of dependence or addiction with Natalac?

As a botanical food supplement and not an approved drug, the product is not psychoactive and is not associated with any known risks or reports of dependence or addiction.

Q: Is Natalac generally safe for older adults (seniors)?

There is limited specific data on using the supplement for lactation in the geriatric population, as this use is not formally established. Regulatory warnings note that older adults are considered a more vulnerable population if the product were to be exposed to microbial contamination.

Q: Does Natalac cause changes in weight?

Weight change is not listed as a common or frequent side effect in official safety profiles. However, limited research has suggested it might lead to a modest increase in Body Mass Index (BMI) in adults, and more research is necessary to confirm this observation.

Q: What has the research evidence shown regarding the long-term use of Natalac?

The active ingredient has been examined in human studies lasting up to six months. Regulatory sources indicate that the follow-up durations of existing trials are often limited, and additional research is necessary to clarify the overall safety and benefits of sustained, long-term use.

Q: Is there a generic version of Natalac available?

Since Natalac is a branded botanical food supplement, and not a conventional drug, it is generally not considered to have a formal 'generic equivalent' in the pharmaceutical patent sense. However, other products containing the same active ingredient, Moringa oleifera leaf powder, are commercially available.

Q: Will taking Natalac affect my routine blood test results?

Clinical trials on the ingredient typically reported no changes in routine hematologic or chemistry values, including standard liver tests. However, due to its documented effects, the product may influence biomarkers related to blood sugar and clotting.

How should Natalac be stored and disposed of?

Storage Conditions for Natalac

The storage requirements for Natalac, a food supplement, are established to maintain the quality and stability of the Moringa oleifera content. The official labeling mandates that the product be kept in a cool and dry place at a temperature not exceeding 30 C.

To ensure product integrity and protection from environmental degradation, capsules must be stored in their original container and protected from both light and moisture. In line with general health product standards, Natalac must always be kept out of the sight and reach of children.

Disposal Instructions

Disposal of unused or expired Natalac must be managed according to local regulations for non-hazardous household waste. It is important to not dispose of the capsules via wastewater (such as flushing them down a toilet) unless specifically instructed to do so by a regulated take-back program.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Natalac found in:

A-Z Index: